drugset / Trial / NCT03317210

Intravenous Treatment of Anemia in Pregnancy

NCT03317210

Phase 4 Completed 50 enrolled University of Zurich
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The investigators assess and compare the efficacy of anemia treatment in pregnant women with anemia of chronic disease with true iron deficiency and in women with iron deficiency anemia.

Timeline

Start
2002-09-01
Primary completion
2006-07-31
Completion
2006-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 200 mg Intravenous
Subject epoetin alfa Protein / enzyme biologic 10000 iu Intravenous

Indications